- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04451967
Acute Myocardial Infarction Study in Northeastern China
June 29, 2020 updated by: Second Hospital of Jilin University
the Acute Myocardial Infarction Study in Northeastern China
This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province.
The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
3159
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jilin
-
Changchun, Jilin, China, 130041
- Recruiting
- The Second Hospital of Jilin University
-
Contact:
- He Wang, Doctor
- Phone Number: 043188796625
- Email: wanghe221@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Eligible patients must be admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, including ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI).
Final inclusion criteria must meet Fourth Universal Definition for Myocardial Infarction (2018)
Description
Inclusion Criteria:
- patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)
Exclusion Criteria:
- Types 4a and type 5 AMI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transfer after thrombolysis
|
transfer after thrombolysis for STEMI patients within 6h since onset
Other Names:
|
Transfer after DAPT
|
|
Direct transfer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
all-cause death
Time Frame: 2 years post discharge
|
all-cause death
|
2 years post discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
major adverse cardiac events (MACE)
Time Frame: 2 years post discharge
|
recurrent angina, non-fatal myocardial infarction, cardiac failure, malignant arrhythmia, and death from cardiovascular causes
|
2 years post discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Bin Liu, Ph.D, Second Hospital of Jilin University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 9, 2019
Primary Completion (Anticipated)
September 9, 2020
Study Completion (Anticipated)
September 9, 2022
Study Registration Dates
First Submitted
June 26, 2020
First Submitted That Met QC Criteria
June 29, 2020
First Posted (Actual)
June 30, 2020
Study Record Updates
Last Update Posted (Actual)
June 30, 2020
Last Update Submitted That Met QC Criteria
June 29, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SecondJilinU-AMINoC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myocardial Infarction
-
Henry Ford Health SystemAbiomed Inc.Enrolling by invitationAcute Myocardial Infarction | Cardiogenic Shock | STEMI | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction | NSTEMI | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction of Right Ventricle (Disorder) | Acute Myocardial Infarction of Left VentricleUnited States
-
Jordan Collaborating Cardiology GroupCardiovascular Academy GroupTerminatedTriggers of Acute Myocardial Infarction | Time of Onset of Acute Myocardial Infarction | Long-term Prognosis After Acute Myocardial InfarctionJordan
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
Medical Center of South ArkansasWithdrawnAcute Coronary Syndrome | Acute ST Segment Elevation Myocardial InfarctionUnited States
-
Yuan's General HospitalKaohsiung Veterans General Hospital.; Sin-Lau HospitalUnknownAcute Myocardial Infarction, of Inferolateral Wall | Acute Myocardial Infarction, of Inferoposterior WallTaiwan
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Acute Coronary Syndrome | Acute Myocardial Infarction | Metabolic DisturbanceGreece
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Sheba Medical CenterCompletedNon ST Elevation Myocardial Infarction | Acute Coronary SyndromesIsrael
-
Medstar Health Research InstituteWithdrawnST-elevation Myocardial Infarction | Acute Myocardial InfarctionUnited States
-
Hennepin Healthcare Research InstituteSiemens HealthineersActive, not recruitingAcute Coronary Syndrome | Acute Myocardial InfarctionUnited States
Clinical Trials on thrombolysis
-
Chengdu University of Traditional Chinese MedicineRecruitingDeep Vein Thrombosis | Pharmacomechanical ThrombolysisChina
-
Oslo University HospitalRecruitingSTEMI - ST Elevation Myocardial InfarctionNorway
-
University Hospital Inselspital, BerneUniversity of Zurich; University Hospital, Geneva; University Hospital, Basel... and other collaboratorsCompletedIschemic StrokeSwitzerland
-
Centre Hospitalier Universitaire VaudoisThe University of Texas Health Science Center, Houston; Charite University,... and other collaboratorsCompletedArterial Occlusive Diseases | Ischemic Stroke | Vertebrobasilar Insufficiency | Vertebral Artery IschemiaSwitzerland
-
University of LeicesterCompleted
-
Emory UniversityCompletedCardiovascular DiseasesUnited States
-
University of Toledo Health Science CampusWithdrawnPost Thrombotic Syndrome | Deep Venous ThrombosisUnited States
-
Piedmont HealthcareCompletedSubmassive Pulmonary EmbolismUnited States
-
Second Hospital of Jilin UniversityUnknownAcute ST Segment Elevation Myocardial InfarctionChina
-
IRCCS San RaffaeleRecruitingPost-Thrombotic Syndrome of Both LegsItaly